Last viewed: GBT

Prices are updated after-hours

GBT Nasdaq

Global Blood Therapeutics, Inc.

GBT | $68.49 0.02% -0.02%

|

Health Technology

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (73.96% volume)
Earnings Calendar: 2022-11-03
Market Cap: $ 4,621,443,500
http://www.gbt.com
Sec Filling | Patents | 352 employees

(US) Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.

t-cell ceiling

Drugs

OXBRYTA (Voxelotor)

add to watch list Paper trade email alert is off

Press-releases

Aligos Therapeutics Strengthens Finance Leadership Team with Two New Appointments
Published: 2024-02-13 (Crawled : 13:00) - globenewswire.com
CWBR | $0.9004 -11.88% 21

|

Health Technology

| -7.57% | O: 6.09% H: 0.0% C: -17.23%
CDNA | $7.995 -2.86% -2.94% 520K

|

Health Technology

| -12.02% | O: -7.39% H: 2.74% C: -5.24%
ALGS | $0.8204 -0.39% -0.39% 640K

|

Health Technology

| 22.06% | O: 1.47% H: 1.45% C: -7.54%
therapeutics

Sickle Cell Disease Clinical Trial Pipeline Accelerates as 40+ Pharma Companies Rigorously Developing Drugs for the Market Entry
Published: 2023-07-11 (Crawled : 21:00) - prnewswire.com
DTIL | $9.81 -4.11% -4.28% 34K

|

Health Technology

| 1535.03% | O: 1.57% H: 19.67% C: 9.97%
BLUE | $0.9274 -4.45% -4.66% 8.1M

|

Health Technology

| -74.66% | O: 2.2% H: 0.27% C: -1.62%
BLRX | $0.5966 -6.31% -6.74% 760K

|

Health Technology

| -64.12% | O: 0.0% H: 2.94% C: -0.59%
pharma disease companies pipeline cell trial market

Sickle Cell Disease Market to Observe Impressive Growth, Predicts DelveInsight | Key Companies Active in the Domain - Sanofi, Novartis, Vertex, CRISPR, Vifor, Pfizer, GlaxoSmithKline, Alexion, Global Blood
Published: 2023-05-22 (Crawled : 15:00) - prnewswire.com
VRTX | $400.66 -1.05% -1.06% 810K

|

Health Technology

| 17.28% | O: 0.69% H: 0.56% C: -1.19%
SNY | News | $46.66 -2.16% -2.21% 1.7M

|

Health Technology

| -13.36% | O: -0.75% H: 0.0% C: 0.0%
EDIT | News | $5.355 -1.92% -1.96% 1.6M

|

Health Technology

| -42.6% | O: -0.97% H: 4.98% C: 4.44%
BEAM | $22.74 -3.11% -3.21% 1.1M

|

Health Technology

| -34.16% | O: 0.2% H: 2.51% C: 1.56%
AGIO | $31.67 -0.44% -0.44% 540K

|

Health Technology

| 21.34% | O: 0.38% H: 2.48% C: 1.87%
disease companies active cell blood global market

Tarsus Appoints Jeff Farrow as Chief Financial Officer and Chief Strategy Officer
Published: 2023-04-24 (Crawled : 13:00) - biospace.com/
TARS | $32.77 -2.79% -2.87% 320K

|

Health Technology

| 119.13% | O: -1.47% H: 0.75% C: -0.75%
financial

ElevateBio Appoints Heidi L. Wagner, J.D., as Global Head of Government Affairs
Published: 2023-03-07 (Crawled : 14:00) - biospace.com/
GBT | $68.49 0.02% -0.02%

|

Health Technology

| Email alert Add to watchlist
global

PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE
Published: 2023-01-31 (Crawled : 13:00) - biospace.com/
GLAXF | News | $19.54 -14.18% 2.6K

|

Health Technology

| 12.66% | O: 2.04% H: 0.0% C: -3.67%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

|

Health Technology

| -39.68% | O: -1.26% H: 2.97% C: 2.7%
GSK | News | $40.86 -0.92% -0.15% 1.7M

|

Health Technology

| 16.34% | O: 0.85% H: 0.31% C: -0.45%
BHVN | News | $38.72 -2.25% -0.28% 970K

|

Health Technology

| 108.4% | O: -0.48% H: 4.49% C: 3.24%
BNTX | News | $88.18 -0.35% -0.35% 280K

|

Health Technology

| -37.3% | O: -1.74% H: 4.84% C: 3.88%
BEAM | $22.74 -3.11% -3.21% 1.1M

|

Health Technology

| -45.99% | O: 0.21% H: 4.84% C: 2.99%
financial results

LAMEA Attention Deficit Hyperactivity Disorder Market 2022: Sector to Grow by 7.3% Annually Through 2028
Published: 2023-01-18 (Crawled : 12:00) - prnewswire.com
MNK | $0.3402 -0.06% 540K

|

| -94.91% | O: -0.13% H: 3.25% C: -3.0%
NVSEF | News | $96.0 6.88% 52K

|

Health Technology

| 25.97% | O: 0.05% H: 0.0% C: 0.0%
TAK | News | $13.23 -1.12% 0.0% 920K

|

Health Technology

| -18.08% | O: 0.62% H: 0.12% C: -0.68%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

|

Health Technology

| -42.99% | O: -1.16% H: 0.67% C: -1.2%
NVS | News | $98.35 1.1% 0.0% 2.2M

|

Health Technology

| 6.46% | O: 0.93% H: 0.01% C: -1.16%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

|

Health Technology

| -14.05% | O: -0.41% H: 0.2% C: -1.1%
LLY | News | $732.2 -1.81% 0.18% 2.1M

|

Health Technology

| 110.27% | O: -0.4% H: 0.75% C: -1.21%
SUPN | $30.26 1.04% 1.02% 200K

|

Health Technology

| -24.5% | O: 0.07% H: 2.69% C: 0.32%
market

Global Hemoglobinopathies Market Report 2022: Rising Cases in Under-Developed Countries Boosts Growth
Published: 2023-01-16 (Crawled : 14:00) - prnewswire.com
ALNY | $143.8 -1.55% -1.58% 390K

|

Health Technology

| Email alert Add to watchlist
GBT | $68.49 0.02% -0.02%

|

Health Technology

| Email alert Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M

|

Health Technology

| Email alert Add to watchlist
ABT | News | $106.89 -0.65% -0.22% 5.1M

|

Health Technology

| Email alert Add to watchlist
DHR | $250.41 -1.07% -0.72% 3.3M

|

Health Technology

| Email alert Add to watchlist
PFE | News 4 | $26.27 -0.19% -0.15% 23M

|

Health Technology

| Email alert Add to watchlist
EMMA | $0.0921 385.44% 66K

|

Professional, Scientific, and T...

| Email alert Add to watchlist
SNYNF | News | $94.25 -2.18% 480

|

Health Technology

| Email alert Add to watchlist
global report growth market

Global Hemoglobinopathies Market Report to 2031 - Featuring Abbott Laboratories, Alnylam Pharmaceuticals, Biogen Idec and Bluebird Among Others
Published: 2022-11-21 (Crawled : 16:00) - prnewswire.com
EMMA | $0.0921 385.44% 66K

|

Professional, Scientific, and T...

| -70.44% | O: 33.02% H: 0.0% C: -21.11%
ARVL | News | $0.49 0.37% 2.5M

|

| 33.97% | O: -5.8% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M

|

Health Technology

| 14.76% | O: 0.74% H: 0.89% C: 0.53%
DHR | $250.41 -1.07% -0.72% 3.3M

|

Health Technology

| -3.93% | O: -0.32% H: 1.21% C: 0.09%
ABT | News | $106.89 -0.65% -0.22% 5.1M

|

Health Technology

| 2.91% | O: -0.13% H: 1.13% C: 0.14%
SNY | News | $46.66 -2.16% -2.21% 1.7M

|

Health Technology

| 7.29% | O: 1.02% H: 0.0% C: 0.0%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M

|

Health Technology

| -86.58% | O: -1.1% H: 1.66% C: -0.28%
ALNY | $143.8 -1.55% -1.58% 390K

|

Health Technology

| -33.84% | O: 0.22% H: 2.19% C: -5.13%
global report market

Syros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
Published: 2022-11-14 (Crawled : 13:20) - biospace.com/
SYRS | $5.055 -1.65% -1.68% 90K

|

Health Technology

| 27.39% | O: -1.76% H: 2.56% C: -6.39%
pharmaceuticals financial update results

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0000899243-22-033162	4	2022-10-06	2022-10-05	Sell	D	15000	0
0000899243-22-033162	4	2022-10-06	2022-10-05	Sell	D	3600	0
0000899243-22-033162	4	2022-10-06	2022-10-05	Sell	D	37865	0
0000899243-22-033161	4	2022-10-06	2022-10-05	Sell	D	625	0
0000899243-22-033161	4	2022-10-06	2022-10-05	Sell	D	3600	0
0000899243-22-033161	4	2022-10-06	2022-10-05	Sell	D	9037	0
0000899243-22-033163	4	2022-10-06	2022-10-05	Sell	D	30000	0
0000899243-22-033163	4	2022-10-06	2022-10-05	Sell	D	3600	0
0000899243-22-033163	4	2022-10-06	2022-10-05	Sell	D	6637	0

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4323 183.85% 64.77% 220M

|

Consumer Services

BOF | $1.99 70.09% 41.21% 110M

|

ILAG | $0.51 6.03% 40.62% 1.7M

|

LICN | $0.941 68.04% 40.49% 15M

|

AMST | $3.31 65.5% 39.58% 70M

|

Technology Services

MTC | $3.615 61.38% 38.04% 9.3M

|

Technology Services

WIMI | $1.15 58.53% 36.92% 19M

|

Technology Services

AIH | $0.45 12.5% 30.92% 320K

|

Health Services

MULN | News | $3.78 38.46% 27.78% 13M

|

RILY | $29.86 37.48% 27.26% 12M

|

Last 48 Hours Insiders Buying

RKT P 347 | $12.55 -0.63% 0.48% 1.7M

|

| 22:30
NWFL | News | $24.6 2.03% 1.99% 9.9K

|

| 22:00
TGEN P 10000 | $0.685 39.71% 6.6K

|

| 20:01
MNSB P 310 | $15.88 -2.93% -3.02% 46K

|

| 15:30
RMCF | $3.54 0.28% 7.1K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar